Annual EBITDA
-$218.19M$50.54M-30.15%
Summary
- Current Value
- As of today, AGL annual EBITDA is -$218.19M, down -30.15% on
- Historical Performance
- AGL annual EBITDA is up +39.75% over the past 3 years, and down -239.82% over the past 5 years
- All-Time High Comparison
- AGL annual EBITDA is currently -443.98% below its historical high of -$40.11M set on
- 3-Year Low Comparison
- AGL annual EBITDA is at its 3-year low
- Sector Comparison
- AGL annual EBITDA is higher than 6.40% of companies in Healthcare sector
EBITDA Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBITDA | -$218.19M | -30.1% | +39.8% | -239.8% | -239.8% | |
| Quarterly EBITDA | -$119.75M | +4.8% | -368.6% | -1787.9% | -4746.3% | |
| TTM EBITDA | -$341.22M | -6.3% | -350.7% | -5082.6% | -10000.0% | |
| Price | $0.99 | -73.1% | -95.2% | – | – | |
| PE Ratio | - | – | – | – | – | |
| Annual Revenue | $6.06B | +40.4% | +230.5% | +662.9% | +662.9% | |
| Annual EPS | -$0.61 | -16.3% | +39.9% | +15.4% | +15.4% | |
| Annual EBIT | -$242.65M | -29.2% | +35.6% | -129.7% | -129.7% | |
| Annual Net Income | -$250.28M | -28.2% | +38.3% | -118.7% | -118.7% |
EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | -$72.41M | N/A | -201.3% |
| 5Y | -$40.11M | N/A | -444.0% |
| All | -$40.11M | -444.0% |
EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | -$218.19M | at low | |
| 5Y | -$362.16M | +39.8% | |
| All | -$362.16M | +39.8% |
EBITDA History
| Year | Value | Change |
|---|---|---|
| -$218.19M | -30.1% | |
| -$167.64M | -131.5% | |
| -$72.41M | +80.0% |
| Year | Value | Change |
|---|---|---|
| -$362.16M | -802.9% | |
| -$40.11M | +37.5% | |
| -$64.21M | - |
FAQ
What is the current annual EBITDA of AGL?
As of today, AGL annual EBITDA is -$218.19M
What is 1-year change in AGL annual EBITDA?
AGL annual EBITDA is down -30.15% year-over-year
What is 3-year change in AGL annual EBITDA?
AGL annual EBITDA is up +39.75% over the past 3 years
How far is AGL annual EBITDA from its all-time high?
AGL annual EBITDA is currently -443.98% below its historical high of -$40.11M set on December 31, 2020
How does AGL annual EBITDA rank versus sector peers?
AGL annual EBITDA is higher than 6.40% of companies in Healthcare sector
When is AGL next annual earnings release?
The next annual earnings release for AGL is on
Quarterly EBITDA
-$119.75M$11.16M-10.28%
Summary
- Current Value
- As of today, AGL quarterly EBITDA is -$119.75M, down -10.28% on
- Historical Performance
- AGL quarterly EBITDA is up +4.84% year-over-year, and down -368.59% over the past 3 years
- All-Time High Comparison
- AGL quarterly EBITDA is currently -2597.96% below its historical high of $4.79M set on
- 3-Year Low Comparison
- AGL quarterly EBITDA is +24.95% above its 3-year low of -$159.56M reached on
- Sector Comparison
- AGL quarterly EBITDA is higher than 2.27% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBITDA | -$119.75M | -10.3% | +4.8% | -368.6% | -1787.9% | |
| Annual EBITDA | -$218.19M | – | -30.1% | +39.8% | -239.8% | |
| TTM EBITDA | -$341.22M | +1.8% | -6.3% | -350.7% | -5082.6% | |
| Price | $0.99 | +0.5% | -73.1% | -95.2% | – | |
| PE Ratio | - | – | – | – | – | |
| Quarterly Revenue | $1.44B | +2.9% | -1.1% | +106.6% | +359.0% | |
| Quarterly EPS | -$0.27 | -5.4% | +6.0% | -259.3% | -777.6% | |
| Quarterly EBIT | -$127.18M | -9.7% | +3.7% | -338.5% | -1192.0% | |
| Quarterly Net Income | -$110.21M | -5.6% | +5.3% | -261.3% | -795.9% |
Quarterly EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | -$14.71M | -714.1% | |
| 3Y | $4.79M | -2598.0% | |
| 5Y | $4.79M | -2598.0% | |
| All | $4.79M | -2598.0% |
Quarterly EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$119.75M | at low | |
| 3Y | -$159.56M | +24.9% | |
| 5Y | -$294.75M | +59.4% | |
| All | -$294.75M | +59.4% |
Quarterly EBITDA History
FAQ
What is the current quarterly EBITDA of AGL?
As of today, AGL quarterly EBITDA is -$119.75M
What is AGL quarterly EBITDA most recent change?
AGL quarterly EBITDA was down -10.28% on September 30, 2025
What is 1-year change in AGL quarterly EBITDA?
AGL quarterly EBITDA is up +4.84% year-over-year
How far is AGL quarterly EBITDA from its all-time high?
AGL quarterly EBITDA is currently -2597.96% below its historical high of $4.79M set on March 31, 2023
How does AGL quarterly EBITDA rank versus sector peers?
AGL quarterly EBITDA is higher than 2.27% of companies in Healthcare sector
When is AGL next earnings release?
The next earnings release for AGL is on
TTM EBITDA
-$341.22M$6.09M+1.75%
Summary
- Current Value
- As of today, AGL TTM EBITDA is -$341.22M, up +1.75% on
- Historical Performance
- AGL TTM EBITDA is down -6.34% year-over-year, and down -350.72% over the past 3 years
- All-Time High Comparison
- AGL TTM EBITDA is currently -141484.65% below its historical high of -$241.00K set on
- 3-Year Low Comparison
- AGL TTM EBITDA is +1.75% above its 3-year low of -$347.30M reached on
- Sector Comparison
- AGL TTM EBITDA is higher than 2.91% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBITDA | -$341.22M | +1.8% | -6.3% | -350.7% | -5082.6% | |
| Annual EBITDA | -$218.19M | – | -30.1% | +39.8% | -239.8% | |
| Quarterly EBITDA | -$119.75M | -10.3% | +4.8% | -368.6% | -1787.9% | |
| Price | $0.99 | +0.5% | -73.1% | -95.2% | – | |
| PE Ratio | - | – | – | – | – | |
| TTM Revenue | $5.89B | -0.3% | +5.2% | +137.2% | +555.9% | |
| TTM EPS | -$0.78 | +2.1% | +5.2% | -195.7% | -750.0% | |
| TTM EBIT | -$369.34M | +1.3% | -7.5% | -314.0% | -2081.6% | |
| TTM Net Income | -$322.90M | +1.9% | -3.8% | -198.3% | -1267.8% |
TTM EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | -$259.49M | N/A | -31.5% |
| 3Y | -$93.11M | -266.5% | |
| 5Y | -$42.57M | N/A | -701.5% |
| All | -$241.00K | >-9999.0% |
TTM EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$347.30M | +1.8% | |
| 3Y | -$347.30M | +1.8% | |
| 5Y | -$371.52M | +8.2% | |
| All | -$371.52M | +8.2% |
TTM EBITDA History
FAQ
What is the current TTM EBITDA of AGL?
As of today, AGL TTM EBITDA is -$341.22M
What is AGL TTM EBITDA most recent change?
AGL TTM EBITDA was up +1.75% on September 30, 2025
What is 1-year change in AGL TTM EBITDA?
AGL TTM EBITDA is down -6.34% year-over-year
How far is AGL TTM EBITDA from its all-time high?
AGL TTM EBITDA is currently -141484.65% below its historical high of -$241.00K set on June 30, 2020
How does AGL TTM EBITDA rank versus sector peers?
AGL TTM EBITDA is higher than 2.91% of companies in Healthcare sector
When is AGL next earnings release?
The next earnings release for AGL is on
EBITDA Formula
EBITDA = + + +
Data Sources & References
- AGL Official Website www.agilonhealth.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1831097/000162828025048839/0001628280-25-048839-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1831097/000162828025007721/0001628280-25-007721-index.htm
- AGL Profile on Yahoo Finance finance.yahoo.com/quote/AGL
- AGL Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/agl